2020. Efficacy and Safety of Tralokinumab Plus Concomitant Topical Corticosteroids (TCS) in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from the 32-Week, Phase 3 ECZTRA 3 Trial. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s102. DOI:https://doi.org/10.25251/skin.4.supp.102.